The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
Open accessAbstract
Neurotransmitters are molecules that amplify, transmit, and convert signals in cells, having an essential role in information transmission throughout the nervous system. Hundreds of such chemicals have been discovered in the last century, continuing to be identified and studied concerning their action on brain health. These substances have been observed to influence numerous functions, including emotions, thoughts, memories, learning, and movements. Thus, disturbances in neurotransmitters’ homeostasis started being correlated with a plethora of neurological and neurodegenerative disorders. In this respect, the present paper aims to describe the most important neurotransmitters, broadly classified into canonical (e.g., amino acids, monoamines, acetylcholine, purines, soluble gases, neuropeptides) and noncanonical neurotransmitters (e.g., exosomes, steroids, D-aspartic acid), and explain their link with some of the most relevant neurological conditions. Moreover, a brief overview of the recently developed neurotransmitters’ detection methods is offered, followed by several considerations on the modulation of these substances towards restoring homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888 · cited 1×
“Thus, this bacterial strain can be considered an adjuvant therapeutic agent in stress-related disorders, including anxiety and depression [178].”
BackgroundDobson, R., & Giovannoni, G. (2019) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,148
Neurotransmitter modulation by the gut microbiota
Strandwitz, P. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.015 · Cited by 1,527 · cited 4×
“Besides its role as an NT, dopamine is also involved in maintaining homeostasis and is a precursor for other catecholamines, such as norepinephrine and epinephrine [31,57].”
BackgroundInfluentialReigstad, C. S., Salmonson, C. E., III, J. F. R., Szurszewski, J. H., Linden, D. R., Sonnenburg, J. L., Farrugia, G., & Kashyap, P. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-259598 · Cited by 1,335
Diagnosis and Treatment of Multiple Sclerosis: A Review
McGinley, M. P., Goldschmidt, C. H., & Rae-Grant, A. D. (2021) · JAMA · doi:10.1001/jama.2020.26858 · Cited by 1,205
Amyotrophic lateral sclerosis: a clinical review
Masrori, P., & Van Damme, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14393 · Cited by 1,201
γ-Aminobutyric acid production by culturable bacteria from the human intestine
Barrett, E., Ross, R. P., O'Toole, P. W., Fitzgerald, G. F., & Stanton, C. (2012) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2012.05344.x · Cited by 1,156
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Psychobiotics and the manipulation of bacteria–gut–brain signals
Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. J. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.09.002 · Cited by 1,068
Duman, R. S., Sanacora, G., & Krystal, J. H. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.013 · Cited by 1,026
Treatment of Multiple Sclerosis: A Review
Hauser, S. L., & Cree, B. A. C. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.05.049 · Cited by 969
Role of Cholinergic Signaling in Alzheimer’s Disease
Chen, Z.-R., Huang, J.-B., Yang, S.-L., & Hong, F.-F. (2022) · Molecules · doi:10.3390/molecules27061816 · Cited by 922 · cited 1×
“Furthermore, as acetylcholine can regulate the normal cholinergic signal transduction (associated with learning and memory), its low levels in AD patients are no surprise, being manifested through damaged cholinergic signal transduction and cognitive impairment [11,104].”
BackgroundNeuroinflammation as a common feature of neurodegenerative disorders
Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676 · cited 1×
“In relation to PD pathogenesis, exosomes were observed to contain higher amounts of α-synuclein than in healthy controls, readily transporting this protein from the cerebrospinal fluid to blood [79].”
BackgroundGenetics of multiple sclerosis
Dyment, D. A., Ebers, G. C., & Dessa Sadovnick, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00663-x · Cited by 563
Historical review: ATP as a neurotransmitter
Burnstock, G. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.01.005 · Cited by 539
Mustafa, A. K., Gadalla, M. M., & Snyder, S. H. (2009) · Science Signaling · doi:10.1126/scisignal.268re2 · Cited by 496
Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum
Lovinger, D. M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.008 · Cited by 488
Pajarillo, E., Rizor, A., Lee, J., Aschner, M., & Lee, E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.002 · Cited by 478
Autophagy in neurodegenerative diseases: pathogenesis and therapy
Guo, F., Liu, X., Cai, H., & Le, W. (2018) · Brain Pathology · doi:10.1111/bpa.12545 · Cited by 444
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Tam, K., & Ju, Y. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.320970 · Cited by 395
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Iovino, L., Tremblay, M. E., & Civiero, L. (2020) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2020.07.011 · Cited by 374
The emerging role of exosomes in mental disorders
Saeedi, S., Israel, S., Nagy, C., & Turecki, G. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0459-9 · Cited by 370
Quantifying exosome secretion from single cells reveals a modulatory role for GPCR signaling
Verweij, F. J., Bebelman, M. P., Jimenez, C. R., Garcia-Vallejo, J. J., Janssen, H., Neefjes, J., Knol, J. C., de Goeij-de Haas, R., Piersma, S. R., Baglio, S. R., et al. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201703206 · Cited by 359
Calcium signaling and molecular mechanisms underlying neurodegenerative diseases
Pchitskaya, E., Popugaeva, E., & Bezprozvanny, I. (2018) · Cell Calcium · doi:10.1016/j.ceca.2017.06.008 · Cited by 349
GABA ‐producing Bifidobacterium dentium modulates visceral sensitivity in the intestine
Pokusaeva, K., Johnson, C., Luk, B., Uribe, G., Fu, Y., Oezguen, N., Matsunami, R. K., Lugo, M., Major, A., Mori‐Akiyama, Y., et al. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.12904 · Cited by 337
Ueda, K., Shinohara, S., Yagami, T., Asakura, K., & Kawasaki, K. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010265.x · Cited by 319
Revisiting the role of neurotransmitters in epilepsy: An updated review
Akyuz, E., Polat, A. K., Eroglu, E., Kullu, I., Angelopoulou, E., & Paudel, Y. N. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118826 · Cited by 303
A Dopamine Hypothesis of Autism Spectrum Disorder
Pavăl, D. (2017) · Developmental Neuroscience · doi:10.1159/000478725 · Cited by 294
Gene discovery in amyotrophic lateral sclerosis: implications for clinical management
Al-Chalabi, A., van den Berg, L. H., & Veldink, J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.182 · Cited by 287
Czubowicz, K., Jęśko, H., Wencel, P., Lukiw, W. J., & Strosznajder, R. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1448-3 · Cited by 281
Marotta, R., Risoleo, M. C., Messina, G., Parisi, L., Carotenuto, M., Vetri, L., & Roccella, M. (2020) · Brain Sciences · doi:10.3390/brainsci10030163 · Cited by 279
Alterations in cortical interneurons and cognitive function in schizophrenia
Dienel, S. J., & Lewis, D. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.020 · Cited by 272
Reduced GABA and altered somatosensory function in children with autism spectrum disorder
Puts, N. A. J., Wodka, E. L., Harris, A. D., Crocetti, D., Tommerdahl, M., Mostofsky, S. H., & Edden, R. A. E. (2017) · Autism Research · doi:10.1002/aur.1691 · Cited by 265
Ionotropic Glutamate Receptors in Epilepsy: A Review Focusing on AMPA and NMDA Receptors
Hanada, T. (2020) · Biomolecules · doi:10.3390/biom10030464 · Cited by 249
Bi, D., Wen, L., Wu, Z., & Shen, Y. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12088 · Cited by 232
Pan, J.-X., Xia, J.-J., Deng, F.-L., Liang, W.-W., Wu, J., Yin, B.-M., Dong, M.-X., Chen, J.-J., Ye, F., Wang, H.-Y., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0183-x · Cited by 232
β-Alanine as a small molecule neurotransmitter
Tiedje, K. E., Stevens, K., Barnes, S., & Weaver, D. F. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.06.001 · Cited by 214
Roles of β-Endorphin in Stress, Behavior, Neuroinflammation, and Brain Energy Metabolism
Pilozzi, A., Carro, C., & Huang, X. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010338 · Cited by 211
Nimmrich, V., Grimm, C., Draguhn, A., Barghorn, S., Lehmann, A., Schoemaker, H., Hillen, H., Gross, G., Ebert, U., & Bruehl, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4771-07.2008 · Cited by 210
Neurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awx327 · Cited by 202
Dopamine in Health and Disease: Much More Than a Neurotransmitter
Franco, R., Reyes-Resina, I., & Navarro, G. (2021) · Biomedicines · doi:10.3390/biomedicines9020109 · Cited by 199
Krystal, J. H., Anticevic, A., Yang, G. J., Dragoi, G., Driesen, N. R., Wang, X.-J., & Murray, J. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.01.004 · Cited by 195
Madeira, C., Vargas-Lopes, C., Brandão, C. O., Reis, T., Laks, J., Panizzutti, R., & Ferreira, S. T. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00561 · Cited by 193
Jiménez-Balado, J., & Eich, T. S. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 183
Molecular and Cellular Mechanisms Affected in ALS
Gall, L. L., Anakor, E., Connolly, O., Vijayakumar, U. G., Duddy, W. J., & Duguez, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030101 · Cited by 176
Clinical Applications of Artificial Intelligence—An Updated Overview
Busnatu, Ș., Niculescu, A.-G., Bolocan, A., Petrescu, G. E. D., Păduraru, D. N., Năstasă, I., Lupușoru, M., Geantă, M., Andronic, O., Grumezescu, A. M., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082265 · Cited by 172
Self-citationElectrochemical Detection of Neurotransmitters
Banerjee, S., McCracken, S., Hossain, M. F., & Slaughter, G. E. (2020) · Biosensors · doi:10.3390/bios10080101 · Cited by 168
Serotonin in the gastrointestinal tract
Camilleri, M. (2009) · Current Opinion in Endocrinology, Diabetes and Obesity · doi:10.1097/med.0b013e32831e9c8e · Cited by 167
Bukke, V. N., Archana, M., Villani, R., Romano, A. D., Wawrzyniak, A., Balawender, K., Orkisz, S., Beggiato, S., Serviddio, G., & Cassano, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207452 · Cited by 161
Roles of Glutamate Receptors in Parkinson’s Disease
Zhang, Z., Zhang, S., Fu, P., Zhang, Z., Lin, K., Ko, J. K.-S., & Yung, K. K. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184391 · Cited by 159
Rabie, H., Zhang, Y., Pasquale, N. J., Lagos, M. J., Batson, P. E., & Lee, K. (2019) · Advanced Materials · doi:10.1002/adma.201806991 · Cited by 155
Cholinergic modulation of striatal microcircuits
Abudukeyoumu, N., Hernández-Flores, T., Garcia-Munoz, M., & Arbuthnott, G. W. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13949 · Cited by 152
Neame, S., Safory, H., Radzishevsky, I. S., Touitou, A., Marchesani, F., Marchetti, M., Kellner, S., Berlin, S., Foltyn, V. N., Engelender, S., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909458116 · Cited by 152
Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis
Bauer, K. C., Huus, K. E., & Finlay, B. B. (2016) · Cellular Microbiology · doi:10.1111/cmi.12585 · Cited by 151
Ou, Y., Buchanan, A. M., Witt, C. E., & Hashemi, P. (2019) · Analytical Methods · doi:10.1039/c9ay00055k · Cited by 143
Emerging roles of extracellular vesicles in neurodegenerative disorders
You, Y., & Ikezu, T. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104512 · Cited by 143
Mahato, K., Purohit, B., Bhardwaj, K., Jaiswal, A. K., & Chandra, P. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111502 · Cited by 141
A Review of Neurotransmitters Sensing Methods for Neuro-Engineering Research
Niyonambaza, S. D., Kumar, P., Xing, P., Mathault, J., Koninck, P. D., Boisselier, É., Boukadoum, M., & Miled, A. (2019) · Applied Sciences · doi:10.3390/app9214719 · Cited by 140
Findley, C. A., Bartke, A., Hascup, K. N., & Hascup, E. R. (2019) · ASN NEURO · doi:10.1177/1759091419855541 · Cited by 139
A Promising Therapeutic Target for Metabolic Diseases: Neuropeptide Y Receptors in Humans
Yi, M., Li, H., Wu, Z., Yan, J., Liu, Q., Ou, C., & Chen, M. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000486225 · Cited by 137
Jamwal, S., & Kumar, P. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302115032 · Cited by 136
Depression: Biological markers and treatment
Erjavec, G. N., Šagud, M., Perković, M. N., Štrac, D. Š., Konjevod, M., Tudor, L., Uzun, S., & Pivac, N. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110139 · Cited by 136
Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
Tuura, R., Baumann, C. R., & Baumann‐Vogel, H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00806 · Cited by 135
Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases
McGrath, T., Baskerville, R., Rogero, M. M., & Castell, L. M. (2022) · Nutrients · doi:10.3390/nu14050917 · Cited by 134
Liñán-Rico, A., Ochoa‐Cortés, F., Beyder, A., Soghomonyan, S., Zuleta-Alarcón, A., Coppola, V., & Christofi, F. L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00564 · Cited by 131
Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases
Li, C., Wu, X., Liu, S., Zhao, Y., Zhu, J., & Liu, K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00869 · Cited by 131
D‐Aspartic acid is a novel endogenous neurotransmitter
D’Aniello, S., Somorjai, I., García‐Fernàndez, J., Topo, E., & D’Aniello, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-168492 · Cited by 129
Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders
Satarker, S., Bojja, S. L., Gurram, P. C., Mudgal, J., Arora, D. S., & Nampoothiri, M. (2022) · Cells · doi:10.3390/cells11071139 · Cited by 126
Development of a novel micro biosensor for in vivo monitoring of glutamate release in the brain
Ganesana, M., Trikantzopoulos, E., Maniar, Y. M., Lee, S. T., & Venton, B. J. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.01.049 · Cited by 122
Caffeine Induces Neurobehavioral Effects through Modulating Neurotransmitters
Alasmari, F. (2020) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2020.02.005 · Cited by 113
Monoamine transporters: structure, intrinsic dynamics and allosteric regulation
Cheng, M. H., & Bahar, İ. (2019) · Nature Structural & Molecular Biology · doi:10.1038/s41594-019-0253-7 · Cited by 113
Exosome: A novel neurotransmission modulator or non-canonical neurotransmitter?
Xia, X., Wang, Y., Qin, Y., Zhao, S., & Zheng, J. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101558 · Cited by 109
Recent advancement in nanosensors for neurotransmitters detection: Present and future perspective
Chauhan, N., Soni, S., Agrawal, P., Balhara, Y. P. S., & Jain, U. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.12.016 · Cited by 107
Insights into GABA A ergic system alteration in Huntington's disease
Hsu, Y., Chang, Y., & Chern, Y. (2018) · Open Biology · doi:10.1098/rsob.180165 · Cited by 106
Multi-metal, Multi-wavelength Surface-Enhanced Raman Spectroscopy Detection of Neurotransmitters
Moody, A. S., & Sharma, B. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00020 · Cited by 102
N-Acetyl-Aspartyl-Glutamate in Brain Health and Disease
Morland, C., & Nordengen, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031268 · Cited by 101
Recent trends in analytical approaches for detecting neurotransmitters in Alzheimer's disease
Sangubotla, R., & Kim, J. (2018) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2018.05.014 · Cited by 100
GABAergic changes in the thalamocortical circuit in Parkinson's disease
van Nuland, A. J. M., den Ouden, H. E. M., Zach, H., Dirkx, M. F., van Asten, J. J. A., Scheenen, T. W. J., Toni, I., Cools, R., & Helmich, R. C. G. (2019) · Human Brain Mapping · doi:10.1002/hbm.24857 · Cited by 100
Brennenstuhl, H., Jung‐Klawitter, S., Assmann, B. E., & Opladen, T. (2018) · Neuropediatrics · doi:10.1055/s-0038-1673630 · Cited by 98
Actions of Steroids: New Neurotransmitters
Rudolph, L. M., Cornil, C. A., Mittelman-Smith, M. A., Rainville, J. R., Remage‐Healey, L., Sinchak, K., & Micevych, P. E. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.2473-16.2016 · Cited by 96
Optimized method for extraction of exosomes from human primary muscle cells
Gall, L. L., Ouandaogo, Z. G., Anakor, E., Connolly, O., Butler-Browne, G. S., Lainé, J., Duddy, W. J., & Duguez, S. (2020) · Skeletal Muscle · doi:10.1186/s13395-020-00238-1 · Cited by 94
The neurodevelopmental role of dopaminergic signaling in neurological disorders
Cai, Y., Xing, L., Yang, T., Chai, R., Wang, J., Bao, J., Shen, W., Ding, S., & Chen, G. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135540 · Cited by 91
Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus
Govindpani, K., Turner, C. P., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228704 · Cited by 90
The Dopamine Hypothesis of Autism Spectrum Disorder Revisited: Current Status and Future Prospects
Pavăl, D., & Micluția, I. (2021) · Developmental Neuroscience · doi:10.1159/000515751 · Cited by 84
An overview of the detection of serotonin and dopamine with graphene-based sensors
Cernat, A., Ștefan, G., Tertiş, M., Cristea, C., & Şimon, I. (2020) · Bioelectrochemistry · doi:10.1016/j.bioelechem.2020.107620 · Cited by 83
Allosteric Modulation of Neurotransmitter Transporters as a Therapeutic Strategy
Niello, M., Gradisch, R., Loland, C. J., Stockner, T., & Sitte, H. H. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.04.006 · Cited by 82
Onose, G., Anghelescu, A., Blendea, D. C., Ciobanu, V., Daia, C. O., Firan, F. C., Oprea, M., Spînu, A., Popescu, C., Ionescu, A. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020907 · Cited by 78
Cao, G., Edden, R. A. E., Gao, F., Li, H., Gong, T., Chen, W., Liu, X., Wang, G., & Zhao, B. (2017) · European Radiology · doi:10.1007/s00330-017-5064-9 · Cited by 77
Yue, H., Zhang, H., Huang, S., Lu, X. X., Gao, X., Song, S. S., Wang, Z., Wang, W. Q., & Guan, E. H. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110490 · Cited by 76
Murueta‐Goyena, A., Andikoetxea, A., Gómez‐Esteban, J. C., & Gabilondo, I. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01294 · Cited by 72
Zhang, M., & Beyer, C. E. (2005) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2005.07.025 · Cited by 70
Vasopressin, Central Autonomic Control and Blood Pressure Regulation
Lozić, M., Šarenac, O., Murphy, D., & Japundžić‐Žigon, N. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0811-0 · Cited by 70
Electrochemical Nanocomposite Single-Use Sensor for Dopamine Detection
Selvolini, G., Lazzarini, C., & Marrazza, G. (2019) · Sensors · doi:10.3390/s19143097 · Cited by 70
Real-time in vivo detection techniques for neurotransmitters: a review
Su, Y., Bian, S., & Sawan, M. (2020) · The Analyst · doi:10.1039/d0an01175d · Cited by 70
Astrocyte and glutamate involvement in the pathogenesis of epilepsy in Alzheimer's disease
Dejakaisaya, H., Kwan, P., & Jones, N. C. (2021) · Epilepsia · doi:10.1111/epi.16918 · Cited by 69
Restoration and targeting of aberrant neurotransmitters in Parkinson's disease therapeutics
Yadav, D., & Kumar, P. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105327 · Cited by 69
D-Serine as a putative glial neurotransmitter
Mustafa, A. K., Kim, P. M., & Snyder, S. H. (2004) · Neuron Glia Biology · doi:10.1017/s1740925x05000141 · Cited by 68
Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder
Kolodny, T., Schallmo, M., Gerdts, J. A., Edden, R. A. E., Bernier, R., & Murray, S. O. (2020) · Autism Research · doi:10.1002/aur.2300 · Cited by 65
Carbon Monoxide and Nitric Oxide as Examples of the Youngest Class of Transmitters
Nowaczyk, A., Kowalska, M., Nowaczyk, J., & Grześk, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116029 · Cited by 64
Acetylcholinesterase inhibitory activity of novel chitooligosaccharide derivatives
Yoon, N. Y., Ngo, D., & Kim, S. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2009.07.004 · Cited by 63
Kant, R., & Gupta, B. D. (2018) · Journal of Lightwave Technology · doi:10.1109/jlt.2018.2856924 · Cited by 63
Alzheimer’s Disease: An Overview of Major Hypotheses and Therapeutic Options in Nanotechnology
Agarwal, M., Alam, R., Haider, M. K., Malik, M. Z., & Kim, D.-K. (2020) · Nanomaterials · doi:10.3390/nano11010059 · Cited by 63
Alteration of GABA ergic neurotransmission in Huntington's disease
Garret, M., Du, Z., Chazalon, M., Cho, Y. H., & Baufreton, J. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12826 · Cited by 62
Nanomaterials-Based Electrochemical Sensors for In Vitro and In Vivo Analyses of Neurotransmitters
Durairaj, S., Sidhureddy, B., Cirone, J., & Chen, A. (2018) · Applied Sciences · doi:10.3390/app8091504 · Cited by 62
Current advances in the detection of neurotransmitters by nanomaterials: An update
Arumugasamy, S. K., Chellasamy, G., Gopi, S., Govindaraju, S., & Yun, K. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115766 · Cited by 62
Kölker, S. (2018) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-018-0201-4 · Cited by 60
Balasubramanian, P., Balamurugan, T. S. T., Chen, S.-M., & Chen, T. (2019) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b06021 · Cited by 60
Taurine and GABA neurotransmitter receptors, a relationship with therapeutic potential?
la Paz, L. D. O.-D., Zenteno, E., Gulías-Cañizo, R., & Quiroz–Mercado, H. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1593827 · Cited by 57
Nanomaterials for Parkinson disease: Recent progress
Ghazy, E., Rahdar, A., Barani, M., & Kyzas, G. Z. (2020) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2020.129698 · Cited by 56
Mohamed, L. A., Markandaiah, S. S., Bonanno, S., Pasinelli, P., & Trotti, D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.04.002 · Cited by 55
Bhat, S., El‐Kasaby, A., Freissmuth, M., & Sučić, S. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107785 · Cited by 55
Frontal GABA in schizophrenia: A meta-analysis of 1H-MRS studies
Kumar, V., Vajawat, B., & Rao, N. P. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1731925 · Cited by 53
Lénárd, L., László, K., Kertes, E., Ollmann, T., Péczely, L., Kovács, A., Kállai, V., Zagorácz, O., Gálosi, R., & Karádi, Z. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.09.003 · Cited by 51
GABAergic astrocytes in Alzheimer’s disease
Garaschuk, O., & Verkhratsky, A. (2019) · Aging · doi:10.18632/aging.101870 · Cited by 50
Li, Y., Jin, X., Tang, L., Lv, W.-L., Xiao, M., Zhang, Z., Gao, C., & Zhang, G. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00832 · Cited by 47
Astrocytic GABA Accumulation in Experimental Temporal Lobe Epilepsy
Müller, J., Timmermann, A., Henning, L., Müller, H., Steinhäuser, C., & Bedner, P. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.614923 · Cited by 47
Arm, J., Oeltzschner, G., Al‐iedani, O., Lea, R. A., Lechner‐Scott, J., & Ramadan, S. A. (2021) · European Journal of Radiology · doi:10.1016/j.ejrad.2021.109610 · Cited by 46
Glucagon-like Peptide-1 (GLP-1) and neurotransmitters signaling in epilepsy: An insight review
Koshal, P., Jamwal, S., & Kumar, P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.015 · Cited by 45
In Vivo Glutamate Sensing inside the Mouse Brain with Perovskite Nickelate–Nafion Heterostructures
Sun, Y., Nguyen, T. N. H., Anderson, A., Cheng, X., Gage, T. E., Lim, J., Zhang, Z., Zhou, H., Rodolakis, F., Zhang, Z., et al. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c02826 · Cited by 45
Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective
Alcoreza, O. B., Patel, D. C., Tewari, B. P., & Sontheimer, H. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.652159 · Cited by 45
Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
Abreu, C. M., Soares-dos-Reis, R., Melo, P., Relvas, J. B., Guimarães, J., Sá, M. J., Cruz, A., & Pinto, I. M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00164 · Cited by 43
Gao, F., Yin, X., Edden, R. A. E., Evans, A. C., Xu, J., Cao, G., Li, H., Li, M., Zhao, B., Wang, J., et al. (2018) · Hippocampus · doi:10.1002/hipo.23001 · Cited by 42
Emerging Promise of Nanoparticle-Based Treatment for Parkinson’s disease
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.71357151 · Cited by 41
Mobed, A., Hasanzadeh, M., Ahmadalipour, A., & Fakhari, A. (2019) · Analytical Methods · doi:10.1039/c9ay02390a · Cited by 37
Chauhan, N., Balayan, S., & Jain, U. (2020) · Synthetic Metals · doi:10.1016/j.synthmet.2020.116354 · Cited by 37
Kazama, M., Kato, Y., Kakita, A., Noguchi, N., Urano, Y., Masui, K., Niida‐Kawaguchi, M., Yamamoto, T., Watabe, K., Kitagawa, K., et al. (2020) · Neuropathology · doi:10.1111/neup.12716 · Cited by 36
Recent developments of bioanalytical methods in determination of neurotransmitters in vivo
Matys, J., Gieroba, B., & Jóźwiak, K. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.113079 · Cited by 35
Häge, A., Banaschewski, T., Buitelaar, J. K., Dijkhuizen, R. M., Franke, B., Lythgoe, D. J., Mechler, K., Williams, S., & Dittmann, R. (2016) · Trials · doi:10.1186/s13063-016-1266-8 · Cited by 33
Parkinson's disease and glutamate excitotoxicity
Mironova, Y. S., Zhukova, I. A., Zhukova, N., Alifirova, V. M., Izhboldina, O., & Latypova, A. V. (2018) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201811806250 · Cited by 32
Epigenetic modulation by small molecule compounds for neurodegenerative disorders
Singh, A. K., Halder-Sinha, S., Clement, J. P., & Kundu, T. K. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.014 · Cited by 31
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac105.64606473 · Cited by 31
Saitow, F., Takumi, T., & Suzuki, H. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107931 · Cited by 30
New Candidate Delivery System for Alzheimer’s Disease: Deferoxamine Nanogels
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac106.71067119 · Cited by 30
Neuronal excitatory amino acid transporter EAAT3: Emerging functions in health and disease
Underhill, S. M., Ingram, S., Ahmari, S. E., Veenstra-VanderWeele, J. M., & Amara, S. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.05.012 · Cited by 29
Modified Glutamatergic Postsynapse in Neurodegenerative Disorders
Moraes, B. J., Coelho, P., Fão, L., Ferreira, I. L., & Rego, A. C. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.12.002 · Cited by 29
Alamry, K. A., Hussein, M. A., Choi, J., & El-Said, W. A. (2020) · Journal of Electroanalytical Chemistry · doi:10.1016/j.jelechem.2020.114789 · Cited by 29
Genetic and molecular basis of epilepsy-related cognitive dysfunction
Zhu, L., Chen, L., Xu, P., Lu, D., Dai, S., Zhong, L., Han, Y., Zhang, M., Xiao, B., Chang, L., et al. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106848 · Cited by 28
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac111.74687492 · Cited by 28
Abdul, F., Sreenivas, N., Kommu, J. V. S., Banerjee, M., Berk, M., Maes, M. H. J., Leboyer, M., & Debnath, M. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2021-0022 · Cited by 27
Dudina, A., Frey, U., & Hierlemann, A. R. (2019) · Sensors · doi:10.3390/s19143080 · Cited by 23
Mastrangelo, M. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00635-x · Cited by 22
Small Molecules: Therapeutic Application in Neuropsychiatric and Neurodegenerative Disorders
Schiavone, S., & Trabace, L. (2018) · Molecules · doi:10.3390/molecules23020411 · Cited by 19
Juliá‐Palacios, N., Molina‐Anguita, C., Bondarenko, M. S., Cortès‐Saladelafont, E., Aparicio, J., Cuadras, D., Horvath, G. A., Fons, C., Artuch, R., García‐Cazorla, À., et al. (2022) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15140 · Cited by 16
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac103.599609 · Cited by 16
Tsuang, D. W., Greenwood, T. A., Jayadev, S., Davis, M. Y., Shutes‐David, A., & Bird, T. D. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-170277 · Cited by 15
Focal corticarl dysplasia in epilepsy is associated with GABA increase
Gong, T., Liu, Y., Chen, Y., Lin, L., Lin, Y. H., & Wang, G. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102763 · Cited by 14
McCarty, P. J., Pines, A. R., Sussman, B. L., Wyckoff, S. N., Jensen, A., Bunch, R., Boerwinkle, V. L., & Frye, R. E. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100969 · Cited by 11
Kotajima‐Murakami, H., Hagihara, H., Sato, A., Hagino, Y., Tanaka, M., Katoh, Y., Nishito, Y., Takamatsu, Y., Uchino, S., Miyakawa, T., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.821354 · Cited by 11
Cholinesterases Inhibitory Activity of 1H-benzimidazole Derivatives
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac113.1073910745 · Cited by 11
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac104.792796 · Cited by 7
The Relationship between Glutamate and Multiple Sclerosis
Shafaroudi, M. M., Zarei, H., Shafaroudi, A. M., Karimi, N., & Abedini, M. (2018) · International biological and biomedical journal · Cited by 6
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac101.944955 · Cited by 6
Cited by
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
Zheng, Y., Bonfili, L., Wei, T., & Eleuteri, A. M. (2023) · Nutrients · doi:10.3390/nu15214631 · Cited by 175
Lei, W., Cheng, Y., Liu, X., Gao, J., Zhu, Z., Ding, W., Xu, X., Li, Y., Ling, Z., Jiang, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1582119 · Cited by 68
The Intricate Relationship between Circadian Rhythms and Gastrointestinal Peptides in Obesity
Ribeiro, F. M., Arnaldo, L., P. Milhomem, L., S. Aguiar, S., & Franco, O. L. (2025) · Peptides · doi:10.1016/j.peptides.2025.171356 · Cited by 9
Metadata
- Authors
- Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-05-25
- Volume
- 23
- Issue
- 11
- Pages
- 5954
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4281553262
- Cited by
- 596
- References
- 153
- FWCI
- 41.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.